Pharmed Limited Unlisted Shares

BUY AT INR 642.0

1/5

Key Indicators

KEY INDICATORS
2023
FACE VALUE/SHARE
2.0
BOOK VALUE/SHARE
537.3
PRICE TO EARNING (PE)
8.3
PRICE/SALES
0.6
PRICE/BOOK
1.2
OUTSTANDING SHARES (Million)
4.3
MARKET CAP (Rs.Million)
2760.6
DEBT/EQUITY
0.3
DIVIDEND/SHARE
0.0
DIVIDEND % (ON CMP)
0.0%
RETURN ON TOTAL ASSETS
11.4%
RETURN ON EQUITY
14.3%
ROWC
16.7%

* Ratio is calculated based on latest financial & current share price.

About The Company

Pharmed Limited (PL) is engaged in the manufacturing and marketing of pharmaceutical products in orthopedic, gynecologic, general health, pediatric and gastroenterology segments. It offers products of health, joint, bone and tendon health, pain management, cardio-diabetic health; ear, nose, and throat health and many more. The company sells its products under the brands ‘Supracal’, ‘Cartigen’, ‘Absolut’ and ‘Tendocare’. The company has its branch offices located in Bangalore, Mumbai, Delhi, and Kolkata. The company was incorporated in 1946 and has its registered office located in Maharashtra.
Read More

Pricing Trend

Financials

Revenue Growth %

EBDITA Margin %

EPS Growth %

Profit & Loss Summary

(All Amount in INR Millions)

PROFIT & LOSS
2023
2022
2021
2020
2019
2018
PROFIT & LOSS
2023
2022
2021
REVENUE
4360
3596
2863
3199
2734
2330
REVENUE
4360
3596
2863
EXPENSE
3891
3020
2344
2863
2492
2141
EXPENSE
3891
3020
2344
EBDITA
469
576
519
336
241
189
EBDITA
469
576
519
OTHER COST
36
26
23
22
24
23
OTHER COST
36
26
23
PBT
432
550
496
314
217
166
PBT
432
550
496
TAX EXPENSE
102
127
122
74
66
54
TAX EXPENSE
102
127
122
PAT
330
423
374
240
151
112
PAT
330
423
374
OTHER INCOME/EXP.
0
0
0
0
0
0
OTHER INCOME/EXP.
0
0
0
INCOME (NET OF TAXES)
330
423
374
240
151
112
INCOME (NET OF TAXES)
330
423
374
OUTSTANDING SHARE
4
4
4
4
4
4
OUTSTANDING SHARE
4
4
4
EPS ( Rs/share)
76.9
98.4
86.9
55.8
35.2
26.1
EPS ( Rs/share)
76.9
98.4
86.9

Balance Sheet

(All Amount in INR Millions)

BALANCE SHEET
2023
2022
2021
2020
2019
2018
BALANCE SHEET
2023
2022
2021
CASH & CASH EQUIVALENT
127
44
60
61
33
25
CASH & CASH EQUIVALENT
127
44
60
NON CURRENT ASSET
2212
1960
1524
1279
1030
827
NON CURRENT ASSET
2212
1960
1524
CURRENT ASSET
559
618
483
398
456
339
CURRENT ASSET
559
618
483
TOTAL ASSET
2898
2623
2068
1738
1519
1191
TOTAL ASSET
2898
2623
2068
EQUITY SHARE CAPITAL
9
9
9
9
9
9
EQUITY SHARE CAPITAL
9
9
9
RESERVES
2302
1987
1594
1222
979
829
RESERVES
2302
1987
1594
TOTAL EQUITY
2311
1996
1603
1230
987
837
TOTAL EQUITY
2311
1996
1603
NON CURRENT LIABILITY
92
74
64
57
52
48
NON CURRENT LIABILITY
92
74
64
CURRENT LIABILITY
495
553
400
451
480
306
CURRENT LIABILITY
495
553
400
TOTAL LIABILITIES
587
627
465
508
532
354
TOTAL LIABILITIES
587
627
465
TOTAL EQUITY & LIABILITY
2898
2623
2068
1738
1519
1191
TOTAL EQUITY & LIABILITY
2898
2623
2068

Cash Flow Summary

(All Amount in INR Millions)

CASH FLOW
2023
2022
2021
2020
2019
2018
CASH FLOW
2023
2022
2021
OPERATING ACTIVITY
291
398
212
228
213
131
OPERATING ACTIVITY
291
398
212
INVESTING ACTIVITY
-189
-380
-210
-195
-200
-136
INVESTING ACTIVITY
-189
-380
-210
FINANCING ACTIVITY
-19
-33
-4
-5
-5
-4
FINANCING ACTIVITY
-19
-33
-4
NET CASH FLOW
83
-16
-1
28
8
-9
NET CASH FLOW
83
-16
-1

Shareholders

Shareholders
Neha Trust
Sunjeev Arora
Suneet Aurora
Girish Gelli
Nirag Gelli
Indira Bagri
Jani Madhurin
Vaigundi Nagarathnamma
Krishna Murthy
All Others
%
28.0
13.9
1.2
0.2
0.2
0.2
0.1
0.01
0.01
56.0

Registered Address

Management

Suneet Aurora
Chairman & Managing Director
Venkataramani Krishnamurthy
Chief Financial Officer

Annual Reports

Quarterly Reports

NEWS

No data was found

NEWS

MCA tweaks rules; large unlisted private firms have to issue shares in demat forms
Stockify broadens horizons with Mutual funds and dematerialization of shares
Piyush Goyal: Had an engaging interaction with leading business leaders in UAE
Three IPL teams looking to unlock value by public listing, raising PE funds
Unlisted companies may face tough disclosure rules
Stockify Fintech reiterates its vow to help HNIs diversify their stock portfolio
Stockify announces single-window online service to buy unlisted equities
Stockify expands global reach with participation at Dubai Fintech Summit
Stockify offers safe, curated and verified Unlisted or Pre-IPO shares to Indians and NRIs
Back Should retail investors pick IPO shares in pre-market? Key highlights
Unlisted stocks slump as dull listings, IPOs on hold hit sentiment
Why Are Pre-IPO Startup Stocks Bleeding In The Unlisted Market?
Confused About Investing In Unlisted Shares?
Can I buy unlisted shares using my Zerodha demat account?
Unlisted Security : Overview, Types, Risks
India IPO pipeline to continue in 2023 despite global uncertainty
Stockify announces single-window online service to buy unlisted equities
Serum Institute, Byju's, NSE among India's top 10 unlisted companies
Budget 2023: What are the pre-budget expectations for unlisted markets?
Should you invest in unlisted equities during a bull run
Stockify Wealth rechristened Stockify Fintech; To help HNIs diversify their stock portfolio
Budget 2023: After surcharge cap, PE/VCs seek LTCG parity on both unlisted and listed shares
Are You Investing In Unlisted Shares? Here’s The Process And Tax Compliances
Norway wealth fund to consider investing in unlisted equities
Should investors blindly follow the trend and invest in unlisted shares?
Load More

VIDEO NEWS

Polymatech: Update On New Manufacturing Unit, Expansion & More
Unlisted companies may face tough disclosure rules
Load More

Latest Articles From The Experts

No data was found

About Pharmed Limited Unlisted Shares

Pharmed Limited is one of the fastest-growing pharmaceutical companies, established in 1946. Over seven decades, the company has helped millions of people improve their quality of life and carry forward its legacy of “Caring for India.” Headquartered in India’s Silicon Valley, Bangalore, Pharmed Limited has become a renowned company among the Indian medical fraternity and provides a wide range of innovative products.

Pharmed Ltd is a pharmaceutical company that manufactures and markets medicine in many medical fields like orthopaedic, gynaecology, cardio, and many more. It is one of the leading Pharmaceutical companies in India. Additionally, it has many brands under its belt, some examples are MGD3, Supracal, Cartigen, Absoult and many more. Moreover, Pharmed Ltd is backed by many investors and stakeholders.

It promotes these products among dermatologists, Physicians, orthopedic surgeons, Gynaecologists, etc. On this page, we will discuss Pharmed share price, financial performance, and other information in detail.

Different Brands of Pharmed Limited

Pharmed Pharmaceuticals Limited made its name in the pharma industry for its high-quality and evidence-based products. Let’s have a look at the different brands that come under the Pharmed Limited:

 

MGD3

It is the first Indian brand that comes under Pharmed Limited offering bioavailable magnesium to treat subclinical magnesium deficiency. MGD3 is beneficial in providing the body with Vitamin D and offering therapeutic effects.

 

Supracal

Supracal is one of the popular brands under Pharmed Pharmaceuticals Limited that offers calcium citrate, which is considered safe organic calcium. It is available in acid-independent and best-absorbed form.

 

Cartigen

Cartigen is the first Indian brand of Glucosamine, which is used to keep joints healthy and proven in treating the conditions of osteoarthritis.

 

Absoult

It is the popular brand of Pharmed Limited that offers the essential vitamins and minerals to treat various chronic diseases. Absolut is generally known for its health benefits of green tea extract.

 

Tendocare

As the name suggests, Tendocare is a brand which provides medicines for treating tendon degeneration. Pharmed uses this brand to manufacture products that treat the main cause of tendinopathies.

 

FOL 123 MF

FOL 123 MF is a popular brand in India that comes under Pharmed Pharmaceuticals Ltd, which targets women’s problems during pregnancy and lactation. It offers the benefits of iodine with DHA in the form of tablets.

 

Apart from the above, Pharmed also has other brands, including ProLife, OsteoCytic, and Synertab, which targets the specific issue people face in real life. 

An Overview of Pharmed Limited Financial Performance

Pharmed Limited remains in the limelight and is considered one of the preferable investment options among retail investors. Since the company is active in the unlisted share market, its financial performance might impact Pharmed share price. That’s why it is essential to have an overview of its financial performance.

 

As per the data shared by the company on 31 March 2023, Pharmed operational revenue was Rs 425.99 crore and income from other sources was Rs 9.98 crore. The company employee benefits expenses in the last financial year increased from Rs 97.79 crore to Rs 129.79 crore. In addition, Pharmed Limited Profit before tax also decreased from Rs 55.02 crore in FY 2022 to Rs 43.10 crore in FY 2023.

 

The net profit recorded by the company in the last financial year was Rs 9.36 crore. As per the analysis of Pharmed Pharmaceuticals Limited, the company recorded a growth in its operating revenue and net profit. It is also vital for investors to understand that Pharmed Limited recorded stellar growth in the financial year 2021-2022, in which its financial metrics increased. 

Pharmed Share Price History

If we look at the price trend of Pharmed Ltd in the last year, it showed a regular spike in value from August to December 2022 and stood at Rs 420 per equity share. However, Pharmed share price showed growth and touched a mark of Rs 450 per equity share in the early months of 2023. The biggest growth Pharmed Limited recorded in its share price was during May and June 2023, when its share price increased from Rs 580 per equity share to Rs 1000 per equity share. It means the company grew almost 40% in the past few months, which is a positive sign for the investors.

If we take a look at the history of Pharmed Ltd share prices, we can see that the company has been performing quite well in the unlisted share market. The company started offering its unlisted shares in 2019. At that time, the shares were listed at a price of ₹200. As of December 2023, the unlisted share price of Pharmed Ltd is ₹920. This marks a 4.5X ROI for the people who invested in the very beginning. Even in the last 1 year, the company has generated an ROI of 2X for its investors. 

Why Buy Pharmed Limited Unlisted Shares

One of the main reasons to buy Pharmed Ltd unlisted shares is the company’s financials. In the fiscal year 2021-2022, the company’s revenue and net profit were ₹359.6 crore and ₹42.3 crore respectively. In the FY 2022-2023, the revenue increased to ₹436 crore while the net profit came down a little bit at ₹33 crore. This shows that Pharmed Ltd has robust financials.

Check Out Pharmed Share Price On Stockify

As you have an overview of Pharmed Pharmaceuticals Ltd in the last year, you must keep updated with its current share price. You can easily check Pharmed share price in India on Stockify. Our team of expert brokers keep updating the share price based on fresh market data. Right now, the unlisted share price of Pharmed Limited is Rs 920 per equity share.

Check Share Price of Other Unlisted Companies Hassle-Free

Are you looking to buy trending unlisted shares to diversify your investment portfolio? Look no further than Stockify, India’s trusted online trading platform, to buy or sell pre-IPO shares hassle-free. We have top-performing unlisted companies like Tata Technologies, OYO, HDFC Securities, Capgemini, etc. Let’s have a look at the top investing options for you:

 

Reliance Retail, Pharmeasy, Chennai Super Kings, Anglo-French Drugs & Industries, Hexaware Technologies Ltd, Five Star Business Finance Ltd Unlisted Shares, Fincare Small Finance Bank Ltd Unlisted Shares, Arohan Financial Services Unlisted Shares, Utkarsh Coreinvest Ltd Unlisted Shares, Fino Paytech Ltd Unlisted Shares, Hero Fincorp Ltd Unlisted Shares, National Stock Exchange Ltd Nse Unlisted Shares, National Commodity Derivatives Exchange Ltd Ncdex Unlisted Shares, MetroPolitan Stock Exchange MSEI Unlisted Shares, Capital, Small Finance Bank Ltd Unlisted Shares, And Motilal Oswal Home Finance Ltd Unlisted Shares

 

Login To Buy Pharmed Limited Unlisted Shares!

Read More

FAQ On Pharmed Ltd Unlisted Shares

Due to past performance and potential to grow, investment in Pharmed Ltd unlisted shares is a wise choice. At Stockify, you can easily buy and sell unlisted shares of Pharmed Ltd. You just need to connect with our expert share brokers, and they will help you throughout the process.
If you are wondering how to sell Pharmed Ltd shares online, just fill out basic details in the form and our experts will get back to you. Right from the initial deal to the final transfer of shares, our unlisted share brokers will help. Check out the list of the best unlisted shares in India or reach out to reputed unlisted share dealers online.
SEBI has recently reduced the lock-in period from 1 year to 6 months. There is a minimum lock-in period of 6 months from the date of purchase of unlisted shares. However, these shares can be freely transferable before listing in NSE/BSE. Connect with unlisted share experts at +91-80 4113 3935/+91-7353266646
In the recent, unlisted share market in India is spreading its wings and becoming quite big. Some highly recognized companies like Reliance, HDB finance and even the National Stock Exchange are trading unlisted stocks. At Stockify, we allow you to buy and sell any number of Pharmed Ltd unlisted shares as per your budget or needs. Customise your unlisted share trading experience.
Yes, this is 100% legal and safe to buy unlisted shares of Pharmed Ltd. However, this is applicable when you buy Pharmed Ltd unlisted shares from reliable and known unlisted share dealers. You can request a quote or trade online at Stockify, we are ready to assist you.
There is no difference between the tax of unlisted and listed shares. Short-term capital gain taxes are usually paid on the profit of shares held for one year or less. A rate of 15% will be charged as STCG tax and surcharges will be added based on the period of your holding. Buying unlisted shares in bulk? Talk to our experts to learn more.
Applicability of Taxes on Pharmed Ltd unlisted shares once it is listed?
The credit transfer process is also the same for both listed and unlisted stocks. Once the share is transferred it will be reflected in your depositary/Demat account NSDL/CDSL. You can also check it online by logging into the NSDL/CDSL account.
At Stockify, we have simplified the whole process of unlisted share trading. A basic KYC is required for investing in unlisted stocks. For KYC verification, you will need to show Adhar | PAN | Demat CML For NRI |PAN|DEMAT CML| NRO Bank statement. Want to know more about how to buy unlisted shares in India? Connect with expert share brokers today!
There are multiple factors such as Demand/Supply of shares, valuation of the companies & multiple other factors that affect the returns on any unlisted shares. For eg. Investment of 1 Lakh in CSK shares in 2019 is worth 20 lakhs today in 2022 (20x returns in just 3 year). The return on investment of unlisted shares also varies depending on the period of holding. Estimating a return on unlisted shares requires in-depth knowledge and understanding of the industry. So, you can connect with our unlisted share experts to get a greater share of profit.
Due to past performance and potential to grow, investment in Pharmed Ltd unlisted shares is a wise choice. At Stockify, you can easily buy and sell unlisted shares of Pharmed Ltd. You just need to connect with our expert share brokers, and they will help you throughout the process.
As per the financial report shared by the company, it recorded a positive growth in its financials. You can invest in Pharmed pre-IPO shares for future benefits.
The financial performance of the Pharmed indirectly affects its share price in the unlisted share market. However there are other factors involved in it which includes the company’s current performance and market conditions.
Yes, you can buy or sell Pharmed pre-IPO shares hassle-free online by using Stockify. For more info, connect with our experts today.
The short-term capital gain taxes on Pharmed pre-IPO shares is approx 10%. For getting more info about it, contact our experts now!
Yes, you can invest in Pharmed IPO shares in the future. To know more, contact us now!
SHARE
Join Stockify's WhatsApp Community
Stockify Fintech Pvt. Ltd.
Stockify Fintech Pvt. Ltd

Provide Email And Download!~

stockify-fintech-1.png
stockify-fintech-1.png
Provide Email And Download!
Stockify Fintech Pvt. Ltd.

Haven't found what you're looking for?
Speak to an expert.
Book an appointment by clicking on the link below.

Piyush Jhunjhunwala
Piyush Jhunjhunwala
CA, CPA, Ex. PepsiCo, Reckitt, Coty
CEO & Founder
Dubai, UAE.
Rahul Khatuwala
Rahul Khatuwala
Ex. Wipro & Finaco Founder
Co-Founder
Bangalore, India.